Abstract
National trends indicate a longstanding decline in gastric adenocarcinoma due presumably to a decreasing prevalence of Helicobacter pylori infection. Nonetheless, surgical outcomes continue to include relatively high morbidity and mortality rates owing to the advanced stage of disease encountered. We hypothesize that recent immigration patterns are responsible for a leveling off or even reversal of the declining incidence of gastric cancer associated with H. pylori infection. Furthermore, advances in preoperative tumor staging and nonoperative palliation currently permit better patient selection for operation with lower perioperative morbidity and mortality. A retrospective review of a consecutive case series at a public teaching hospital located in an area of high immigration was conducted that included all patients presenting, from 1995 through 2004, with gastric adenocarcinoma. For time comparison purposes, patients were divided into early (1995–1999) and recent (2000–2004) periods. There was no decline in the frequency of gastric adenocarcinoma among the study population over the 10 years. A total of 260 patients were treated of whom 137 (53%) underwent operation. The operation rate decreased and the gastric resection rate increased from the early period to the recent period as fewer incurable advanced stage (M1) patients underwent exploratory laparotomy and were palliated by nonoperative means. Perioperative morbidity and mortality rates also declined over time. Of the four total perioperative deaths, two followed 11 nontherapeutic laparotomies (18% mortality), whereas the only two additional deaths followed 122 curative or palliative laparotomies (2% mortality) (p = 0.034). We conclude that in an area of high immigration there has been no decline in gastric adenocarcinoma rates over the past decade, and the marked reduction in perioperative mortality was due to near elimination of nontherapeutic laparotomy.
Similar content being viewed by others
References
Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: Epidemiology of an unplanned triumph. Epidemiol Rev 1986;8:1–27.
Sipponen P. Helicobacter pylori infection—a common worldwide environmental risk factor for gastric cancer? Endoscopy 1992;24:424–427.
Sipponen P. Helicobacter pylori: A cohort phenomenon. Am J Surg Pathol 1995;19(Suppl 1):S30–S36.
Imrie C, Rowland M, Bourke B, Drumm B. Is Helicobacter pylori infection in childhood a risk factor for gastric cancer? Pediatrics 2001;107:373–380.
Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998;114:1169–1179.
Stabile BE, Smith BR, Weeks DL. Helicobacter pylori infection and surgical disease—Part II. Curr Probl Surg 2005;42:791–862.
Siewert JR, Böttcher K, Stein H, Roder JD. Relevant prognostic factors in gastric cancer. Ten-year results of the German Gastric Cancer Study. Ann Surg 1998;228:449–461.
Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784–789.
Hohenberger P, Gretschel S. Gastric cancer. Lancet 2003;362:305–315.
Stabile BE, Smith BR, Weeks DL. Helicobacter pylori infection and surgical disease—Part I. Curr Probl Surg 2005;42:743–790.
Smith BR, Stabile BE. Emerging trends in peptic ulcer disease and damage control surgery in the H. pylori era. The American Surgeon 2005;71:797–801.
Lim L, Michael M, Mann GB, Leong T. Adjuvant therapy in gastric cancer. J Clin Oncol 2005;25:6220–6232.
Lee YT, Ng EKW, Hung LCT, Chung SCS, Ching JYL, Chan WY, et al. Accuracy of endoscopic ultrasonography in diagnosing ascites and predicting peritoneal metastases in gastric cancer patients. Gut 2005;54:1541–1545.
Conlon KC, Karpeh MS Jr. Laparoscopy and laparoscopic ultrasound in the staging of gastric cancer. Semin Oncol 1996;23:347–351.
Asencio F, Aguilo J, Salvador JL, Villar A, De la Morena E, Ahamad M, et al. Video-laparoscopic staging of gastric cancer: A prospective multicenter comparison with noninvasive techniques. Surg Endosc 1997;11:1153–1158.
Jansen EPM, Boot H, Verheij M, van de Velde CJH. Optimal locoregional treatment in gastric cancer. J Clin Oncol 2005;23:4509–4517.
Valen B, Viste A, Haugstvedt T, Elide GE, Soreido O. Treatment of stomach cancer, a national experience. Br J Surg 1988;75:708–712.
Viste A, Haugstvedt T, Eide E, Soreide O. Postoperative complications and mortality after surgery for gastric cancer. Ann Surg 1988;207:7–213.
Tsioulias GJ, Wood TF, Chung MH, Morton DL, Bilchik A. Diagnostic laparoscopy and laparoscopic ultrasonography optimize the staging and respectability of intraabdominal neoplasms. Surg Endosc 2001;15:1016–1019.
Pollack BJ, Chak A, Sivak MV Jr. Endoscopic ultrasonography. Semin Oncol 1996;23:336–346.
Caletti G, Ferrari A, Brocchi E, Barbara L. Accuracy of endoscopic ultrasonography in the diagnosis and staging of gastric cancer and lymphoma. Surgery 1993;113:14–27.
Chang KJ, Katz KD, Durbin TE, Erickson RA, Bulter JA, Lin F, et al. Endoscopic ultrasound-guided fine-needle aspiration. Gastrointest Endosc 1994;40:694–699.
Stell DA, Carter CR, Steward I, Anderson JR. Prospective comparison of laparoscopy, ultrasonography and computed tomography in the staging of gastric cancer. Br J Surg 1996;83:1260–1262.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Smith, B.R., Stabile, B.E. Gastric Adenocarcinoma: Reduction of Perioperative Mortality by Avoidance of Nontherapeutic Laparotomy. J Gastrointest Surg 11, 127–132 (2007). https://doi.org/10.1007/s11605-006-0019-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-006-0019-5